Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX

Lancet

Volumn 348, Issue 9027, 1996, Pages 584-585

  Barr, Hugh ^a   Shepherd, N A ^a   Dix, A ^a   Roberts, D J H ^b   Tan, W C ^c   Krasner, N ^c  

^a CRANFIELD UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c University Hospital of Aintree   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; DYSPLASIA; ESOPHAGOSCOPY; ESOPHAGUS MUCOSA; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN TISSUE; MALE; ORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 0030608225     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)03054-1     Document Type: Article

References (12)

1. 1 Hameeteman W, Tytgat GNJ, Houthoff HJ, Van Den Tweel JG. Barren's esophagus: development of dysplasia and carcinoma. Gastroenterology 1989; 96: 1249-56.
2. 2 Blot WJ, Devesa SS, Kneller RW, Fraumeni JF. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-89.
3. 3 McFarlane GJ, Boyle P. The epidemiology of oesophageal cancer in UK and other European countries. J R Soc Med 1994; 78: 334-37.
4. 4 Altorki NK, Sunagawa M, Little AG, Skinner D. High-grade dysplasia in columnar-lined esophagus. Am J Surg 1991; 161: 97-100.
5. 5 Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's oesophagus. Gastroenterology 1993; 105: 40-50.
6. 6 Gore S, Healey CJ, Sutton R, et al. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Pharmacol Ther 1993; 7: 623-28.
7. 7 Laukka MA, Wang KK. Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointest Endosc 1995; 42: 59-63.
8. 8 Overhold BF, Panjehpour M. Barrett's esophagus: photodynamic for ablation of dysplasia, reduction of specialized mucosa, and treatment of superficial eosophageal cancer. Gastrointest Endosc 1995; 42: 64-69.
9. 9 Grant WE, Hooper C, MacRobert AJ, Speight PM, Brown SG. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid. Lancet 1993; 342: 147-48.
10. 10 Regula J, MacRobert AJ, Gorchein A, et al. Phososensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX - a pilot study. Gut 1995; 36: 67-75.
11. 11 Loh CS, MacRobert AJ, Buonaccorsi G, Krasner N, Brown SG. Mucosal ablation using photodynamic therapy for the treatment of dysplasia: an experimental study in the normal rat stomach. Gut 1996; 38: 71-78.
12. 12 Berenson MM, Johnson TD, Markowitz NR, Buchl KN, Samowitz WS. Restoration of squamous mucosa after ablation of Barrett's esophageal epithelium. Gastroenterology 1993; 104: 1686-91.